5-LOX Inhibitor with AprèsFlex®
Can promote joint, cell, and arterial health
5-LOX Inhibitor with AprèsFlex®
Can promote joint, cell, and arterial health
For you, if you want to support joint and arterial health with a highly absorbable extract
The compounds in 5-LOX Inhibitor with AprèsFlex® can:
- Support a healthy inflammatory response
- Promote joint and arterial health
- Help maintain a healthy cell division
Boswellia is an extract in which compounds are shown to inhibit inflammatory factors to support joint and arterial health. This supplement contains standardized Boswellia serrata, AprèsFlex®, that can absorb 52% better standard boswellia extracts.
on orders over € 69
We have a 100 days return policy, not the standard 30 days!
Order before 11:00 CET, for same day shipping (Mon-Fri)
We can help you in 6 languages
5-lipoxygenase ( 5-LOX ) is a member of the lipoxygenase family of enzymes. It transforms fatty acids into leukotrienes and, as we age, its levels increase. Excess levels of the enzyme 5-LOX sets in motion inflammatory responses that have been linked to ageing-related effects.
Foods rich in omega-6 fatty acids like red meat, poultry, eggs and dairy products, trigger overproduction of arachidonic acid.
In response to high levels of arachidonic acid, the body produces the 5-LOX enzyme. 5-LOX converts arachidonic acid to pro-inflammatory compounds like leukotriene B4, a molecule that mediates attacks to joints, arterial walls and other tissues.
The good news is that an extract of the Indian plant Boswellia serrata has been shown to neutralise 5-LOX. Used for centuries to help with inflammation, boswellia acts as a natural 5-LOX inhibitor that blocks its unwanted effects.
A boswellia compound called AKBA (3-O-acetyl-11-keto-ß-boswellic acid) seems to be the key behind its beneficial action.
The problem is that boswellia is poorly absorbed into the blood. For this reason, a form of boswellia called AprèsFlex® is introduced, which absorbs into the blood much better than previously available boswellia extracts.
Each 100 mg vegetarian capsule of 5-LOX Inhibitor with AprèsFlex® provides sufficient active AKBA for one day.
AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. International patents pending. | ||||||||||
Dosage and use | ||||||||||
| ||||||||||
Warnings | ||||||||||
|
- Biochim Biophys Acta - Molecular and Cell Biology of Lipids. 2015;1851(4):331-339.
- Faseb j. 2000;14(10):1464-1469.
- Clin Pharmacokinet.2011;50(6):349-369.
- Mol Cell Biol.2011;354(1):189-197.
- Semin Immunol.2017;33:3-15.
- Clin Cancer Res.2005;11(5):2089.